Covid vax from Sanofi, GSK won't be ready until late 2021

 

• Sanofi (NASDAQ:SNY) and GlaxoSmithKline (NYSE:GSK), two of the world's biggest vaccine makers, have delayed advanced trials of their potential coronavirus vaccine after it produced an "insufficient" response in older adults.
• They now say their jab won't be ready until late next year, and will commence a new second-phase study with a more concentrated antigen in February.
• In another setback for vaccine developers, Australia canceled an order for 51M doses of a COVID shot being developed by CSL (OTCPK:CSLLY) and the University of Queensland.
• The Pfizer/BioNTech vaccine looks set for U.S. emergency authorization after the endorsement of an outside panel of experts.
• https://seekingalpha.com/news/3643603-vaccine-from-sanofi-gsk-wont-be-ready-until-late-2021